Made In USAFor Laboratory Research OnlyCOAs Not Yet AvailableExplore Compound Research ProfilesCompare Catalog SizesResearch Requests Reviewed IndividuallyNot For Human Or Veterinary Use
Single compound

KPV

Catalog size
$45
USD per vial · 10 mgCatalog price
Research only

KPV is a three-residue fragment of alpha-MSH studied for cellular inflammatory signaling and intestinal inflammation in preclinical models.

Explore the research profile

Submit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.

No reservation or purchase is made by adding a material.
View documentation status ← Back to collection
Material
KPV
Format
Awaiting confirmation
Availability
Confirmed during review

Catalog quantities are not assay results.

In the literature

A closer look at the science.

Alpha-MSH-derived tripeptide

What is KPV?

KPV denotes the amino acids lysine, proline, and valine, corresponding to the final three residues of alpha-melanocyte-stimulating hormone. Studying this short fragment does not make it interchangeable with the complete hormone. Most relevant evidence concerns cultured cells and experimental intestinal inflammation in mice.

Reference identity
Research class
Alpha-MSH-derived tripeptide
Sequence
Lysine–proline–valine
Parent region
Final three residues of alpha-MSH

This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.

Mechanisms under investigation

A mechanistic study identified uptake through the peptide transporter PepT1 in intestinal epithelial and immune-cell models, followed by reduced activation of inflammatory signaling pathways including NF-kappaB and MAP kinases. Separate mouse experiments suggest that some effects can occur without a functional melanocortin-1 receptor.

Documented lines of inquiry

Research areas

  1. 01

    Cellular transport and signaling

    Experiments using epithelial cell lines and a T-cell line linked KPV transport to reduced inflammatory responses. These systems help examine how access to intracellular compartments affects activity; human-derived cells are not evidence from treated human participants. [1]

  2. 02

    Experimental colitis

    A study using chemically induced and immune-cell-transfer colitis reported changes in weight recovery, inflammatory infiltrates, and tissue injury. Findings in mice lacking functional melanocortin-1 receptors supported investigation of mechanisms beyond that receptor alone. [2]

  3. 03

    Targeted delivery

    Researchers incorporated KPV into hyaluronic-acid-functionalized nanoparticles to investigate delivery to inflamed intestinal tissue. The resulting mouse findings concern an engineered formulation, so they cannot be assigned automatically to free KPV or a different preparation. [3]

Study topics describe the cited models, not established benefits of this catalog material.

Reading the evidence

What the studies
can tell us.

Cell and animal evidence; clinical efficacy unestablished

The cited work supports preclinical investigation of transport, local inflammatory signaling, and formulation design. It does not demonstrate treatment of human inflammatory bowel disease. Reduced inflammatory markers and improved mouse disease scores remain intermediate evidence rather than established clinical outcomes.

What remains uncertain

Transporter expression, disease model, tissue exposure, and delivery system can substantially change experimental results. The presence of a fragment within a natural hormone does not establish the safety or effectiveness of supplying that fragment separately. No cited study validates a WYZ Labs formulation or proves benefit in people.

Read the source

Selected literature

Primary studies and clearly identified supporting sources. Each link opens the original record.

  1. 01
    2008 · Cell and animal study

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation (opens a new tab)

    PepT1 uptake and inflammatory signaling in cell systems, with mouse colitis experiments.

    PubMed
  2. 02PubMed
  3. 03
    2017 · Animal and formulation study

    Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis (opens a new tab)

    Engineered nanoparticle delivery in preclinical systems; not a human ulcerative-colitis trial.

    PubMed

Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.

Before you begin

The details behind
the material.

Specifications and storage

Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.

Research use only

For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.

What to look for in a COA
Before you explore

Laboratory
research only.

Please confirm the following to enter the Wyz Labs collection.

Select both confirmations to continue.

Your acknowledgment is remembered for this browser session. This is a self-declaration, not identity verification.